Literature DB >> 19687094

The changing epidemiology of lung cancer with a focus on screening.

Gerard A Silvestri1, Anthony J Alberg, James Ravenel.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19687094     DOI： 10.1136/bmj.b3053

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

1.  RBMS3 is a tumor suppressor gene that acts as a favorable prognostic marker in lung squamous cell carcinoma.

Authors:  Ya-Nan Liang; Yu Liu; Qingwei Meng; Xiaobo Li; Fan Wang; Guodong Yao; Letian Wang; Songbin Fu; Dandan Tong
Journal:  Med Oncol       Date:  2015-01-15       Impact factor: 3.064

2.  Identifying patients with suspected lung cancer in primary care: derivation and validation of an algorithm.

Authors:  Julia Hippisley-Cox; Carol Coupland
Journal:  Br J Gen Pract       Date:  2011-11       Impact factor: 5.386

Review 3.  [Lung cancer from the perspective of internal medicine and surgery].

Authors:  A Prasse; C Waller; B Passlick; J Müller-Quernheim
Journal:  Radiologe       Date:  2010-08       Impact factor: 0.635

4.  Early lung cancer detection using the self-evaluation scoring questionnaire and chest digital radiography: a 3-year follow-up study in China.

Authors:  Bojiang Chen; Youjuan Wang; Huibi Cao; Dan Liu; Shangfu Zhang; Jun Gao; Jianqun Yu; Yan Huang; Weimin Li
Journal:  J Digit Imaging       Date:  2013-02       Impact factor: 4.056

Review 5.  Cancer diagnosis in primary care.

Authors:  William Hamilton
Journal:  Br J Gen Pract       Date:  2010-02       Impact factor: 5.386

6.  Magnetised thermo responsive lipid vehicles for targeted and controlled lung drug delivery.

Authors:  Dhrumil Upadhyay; Santo Scalia; Robert Vogel; Nial Wheate; Rania O Salama; Paul M Young; Daniela Traini; Wojciech Chrzanowski
Journal:  Pharm Res       Date:  2012-05-15       Impact factor: 4.200

7.  Nanopore-based detection of circulating microRNAs in lung cancer patients.

Authors:  Yong Wang; Dali Zheng; Qiulin Tan; Michael X Wang; Li-Qun Gu
Journal:  Nat Nanotechnol       Date:  2011-09-04       Impact factor: 39.213

8.  Long-term outcomes of stereotactic body radiation therapy (SBRT) with fiducial tracking for inoperable stage I non-small cell lung cancer (NSCLC).

Authors:  Jonathan W Lischalk; Stephanie M Woo; Shaan Kataria; Nima Aghdam; Ima Paydar; Michael C Repka; Eric D Anderson; Brian T Collins
Journal:  J Radiat Oncol       Date:  2016-08-20

9.  [Aberrant expression of HDGF and its prognostic values in surgically resected non-small cell lung cancer].

Authors:  Jun Zhang; Juan Qi; Yan Guo; Yi Guo; Weineng Fu; Baosen Zhou; Guangping Wu; Libo Han; Anguang He
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-03

10.  TGFβ upregulates PAR-1 expression and signalling responses in A549 lung adenocarcinoma cells.

Authors:  Natalia Smoktunowicz; Manuela Platé; Alejandro Ortiz Stern; Vanessa D'Antongiovanni; Eifion Robinson; Vijay Chudasama; Stephen Caddick; Chris J Scotton; Gabor Jarai; Rachel C Chambers
Journal:  Oncotarget       Date:  2016-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.